Author: OurCrowd

[Biolojic in GlobeNewswire] Biolojic Design announces that Nektar Therapeutics has exercised its license option to develop an AI-designed agonistic antibody targeting TNFR2 for the treatment of autoimmune diseases

TEL AVIV, Israel and SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar exercised its license option to develop a program resulting from the companies’ research collaboration initiated in 2021. Read...

Read More

[Stellar Cyber in BusinessWire] Stellar Cyber Launches MITRE ATT&CK Coverage Analyzer for Partners and Customers

SAN JOSE, Calif.–(BUSINESS WIRE)–Stellar Cyber, the inventor of Open XDR technology, announced the launch of the MITRE ATT&CK Coverage Analyzer, enabling users to quickly visualize the impact of data source changes on their ability to detect threats in their specific environments. With this new tool, free of charge to all existing customers, security teams can easily baseline their existing MITRE ATT&CK coverage and then run various data sourcing scenarios, getting real-time feedback. This instant ability to model data sourcing options ensures security teams make the right decisions to get the desired security coverage. Read more...

Read More